Novo Nordisk was slammed by a U.K. trade group for not disclosing payments to health and patient groups, according to a draft ...

The Trump administration has pressed the pause button on the US’ vital biomedical research engine, the National Institutes ...

Though not quite reaching 2023’s highs, healthcare bankruptcies remained elevated across 2024 with a six-year high among ...

Pharma: Launch of Shortages Monitoring Platform, several Changes re Clinical Trial Management in EU Countries; Devices: Resolution on the need ...

Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...

Kennedy’s potential ascent as HHS secretary brings promise for backers of alternative-health approaches, while skeptics say ...

President Donald Trump is pulling the U.S. out of the World Health Organization, raising concerns about the U.N. agency's ...

With President Donald Trump back in the White House, several American doctors are welcoming the new administration’s greater ...

RFK Jr.'s call to ban TV advertisements for prescription drugs reignited support for a bipartisan bill that would mandate the ...

Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.

Bangladesh’s health sector reforms must prioritise health as a constitutional right, fair wages for workers, and improved infrastructure. Strengthening primary care, addressing nutrition-related ...